Evidence map›Paper›PMID 33170939›Full record

ArticleChinese journal of integrative medicine2021

Standard Operating Procedures for Chinese Medicine Data Monitoring Committees of Clinical Studies.

Jun Liu, Nian Wang, Hai-Xia Dang, Bing-Wei Chen, Li Zhang, Chong Zou, Cheng-Liang Zhong, Ju-Kai Huang, Qiong Liu, Ya-Nan Yu and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Chinese journal of integrative medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jun LiuInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Nian WangInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Hai-Xia DangChina Academy of Chinese Medical Sciences, Beijing, 100700, China.
Bing-Wei ChenSchool of Public Health, Southeast University, Nanjing, 210009, China.
Li ZhangDongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100078, China.
Chong ZouJiangsu Provincial Hospital of Traditional Chinese Medicine (Affiliated Hospital of Nanjing University of Traditional Chinese Medicine), Nanjing, 210029, China.
Cheng-Liang ZhongFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300381, China.
Ju-Kai HuangDongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100078, China.
Qiong LiuInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Ya-Nan YuInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Meng JiangJiangsu Provincial Hospital of Traditional Chinese Medicine (Affiliated Hospital of Nanjing University of Traditional Chinese Medicine), Nanjing, 210029, China.
Wei-Xiong LiangGuangdong Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Qi-Guang ChenSchool of Public Health, Southeast University, Nanjing, 210009, China.
Yong-Yan WangInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Chun-Ti ShenChangzhou Traditional Chinese Medicine Hospital, Changzhou, Jiangsu Province, 213004, China.
Zhong WangInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China. zhonw@vip.sina.com.
World Federation of Chinese Medicine Societies—Data Monitoring Committee for Clinical Studies

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although there is guidance from different regulatory agencies, there are opportunities to bring greater consistency and stronger applicability to address the practical issues of establishing and operating a data monitoring committee (DMC) for clinical studies of Chinese medicine. We names it as a Chinese Medicine Data Monitoring Committee (CMDMC). A panel composed of clinical and statistical experts shared their experience and thoughts on the important aspects of CMDMCs. Subsequently, a community standard on CMDMCs (T/CACM 1323-2019) was issued by the China Association of Chinese Medicine on September 12, 2019. This paper summarizes the key content of this standard to help the sponsors of clinical studies establish and operate CMDMCs, which will further develop the scientific integrity and quality of clinical studies.

Indexed as

Clinical Trials Data Monitoring CommitteesMedicine, Chinese TraditionalChinaChinese medicineChinese Medicine Data Monitoring Committeeclinical trialcommunity standarddata monitoring committee

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.